Celgene (CELG ) Tops Q2 EPS by 4c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- Moderna shares rise ahead of Thursday earnings report
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Celgene (CELG) PT Lifted to $167 at Nomura on Building Momentum
July 24, 2015 10:40 AM EDTNomura Securities analyst M. Ian Somaiya reiterated his Buy rating and boosted his price target on Celgene (NASDAQ: CELG) to $167.00 (from $165.00) following 2Q earnings, which saw largely in-line revenue, but an EPS beat on continued operating leverage.
Somaiya commented, "We believe... More
Celgene (CELG) PT Lifted to $150 at Cowen Amid Solid Q2
July 23, 2015 11:19 AM EDTCowen analyst Eric Schmidt bumped his price target on Outperform-rated Celgene (NASDAQ: CELG) to $150.00 (from $146.00) following solid Q2 results.
Schmidt commented, "Celgene reported Q2 sales of $2.254B (+22% Y/Y) and non-GAAP EPS $1.17 (+30% Y/Y, excluding 1x gain of $0.06), in-line with its... More



